E. Giordani

发表

Bioassay engineering: a combined label-free and fluorescence approach to optimize HER2 detection in complex biological media

F. Michelotti, N. Danz, P. Giacomini, 2020, Analytical and Bioanalytical Chemistry.

Optical multiplexed bioassays on photonic crystals for breast cancer biomarker detection

F. Sonntag, F. Michelotti, N. Danz, 2021, EPJ Web of Conferences.

A Distinctive microRNA (miRNA) Signature in the Blood of Colorectal Cancer (CRC) Patients at Surgery

C. Scapoli, R. Gambari, A. Finotti, 2020, Cancers.

Circulating microRNAs and liquid biopsy: murine xenograft models for technical validation of clinical protocols

R. Gambari, A. Finotti, P. Giacomini, 2019, Journal of Cancer Metastasis and Treatment.

Liquid biopsy identifies actionable dynamic predictors of resistance to Trastuzumab Emtansine (T-DM1) in advanced HER2-positive breast cancer

G. Ciliberto, E. Pescarmona, F. Cognetti, 2021, Molecular cancer.

Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach

G. Ciliberto, M. Fanciulli, P. Giacomini, 2023, International journal of molecular sciences.

Cross-sectional analysis of circulating tumor DNA in primary colorectal cancer at surgery and during post-surgery follow-up by liquid biopsy

F. Spinella, G. Cigliana, B. Casini, 2020, Journal of experimental & clinical cancer research : CR.

Unusual phylogenetic tree and circulating actionable ESR1 mutations in an aggressive luminal/HER2-low breast cancer: Case report

G. Ciliberto, A. Fabi, P. Giacomini, 2023, Frontiers in Oncology.

Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers

S. Cingarlini, G. Sala, C. Tito, 2023, Heliyon.

The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world

L. Landi, G. Minuti, E. Pescarmona, 2023, Journal of Translational Medicine.